News archives


OCTOBER - DECEMBER 17

JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   selected story    
     
  10 November 2017  
 
ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer
 
 




Authors
Chen-Ying Liu‡,§, Tong Yu, Yuji Huang, Long Cui and Wanjin Hong§

Author Affiliations
 Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of   Medicine, Shanghai 200092, China

§ Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), 61   Biopolis Drive, Proteos, Singapore 138673, Singapore

Published in J Biol Chem, Jun 2;292(22):9420-9430. Epub 2017 Apr 13.

Abstract
Prostate cancer is a very common malignant disease and a leading cause of death for men in the Western world. Tumorigenesis and progression of prostate cancer involves multiple signaling pathways, including the Hippo pathway. Yes-associated protein (YAP) is the downstream transcriptional co-activator of the Hippo pathway, is overexpressed in prostate cancer, and plays a vital role in the tumorigenesis and progression of prostate cancer. However, the role of the YAP paralog and another downstream effector of the Hippo pathway, transcriptional co-activator with PDZ-binding motif (TAZ), in prostate cancer has not been fully elucidated. Here, we show that TAZ is a basal cell marker for the prostate epithelium. We found that overexpression of TAZ promotes the epithelial-mesenchymal transition (EMT), cell migration, and anchorage-independent growth in the RWPE1 prostate epithelial cells. Of note, knock down of TAZ in the DU145 prostate cancer cells inhibited cell migration and metastasis. We also found that SH3 domain binding protein 1 (SH3BP1), a RhoGAP protein that drives cell motility, is a direct target gene of TAZ in the prostate cancer cells, mediating TAZ function in enhancing cell migration. Moreover, the prostate cancer-related oncogenic E26 transformation-specific (ETS) transcription factors, ETV1, ETV4, and ETV5, were required for TAZ gene transcription in PC3 prostate cancer cells. MAPK inhibitor U0126 treatment decreased TAZ expression in RWPE1 cells, and ETV4 overexpression rescued TAZ expression in RWPE1 cells with U0126 treatment. Our results show a regulatory mechanism of TAZ transcription and suggest a significant role for TAZ in the progression of prostate cancer.

Figure

Figure legend
: TAZ is a basal cell marker for prostate epithelium. (A) Immunohistochemical analysis of TAZ in normal prostate epithelium, hyperplasia and prostate cancer tissues. The representative images of TAZ in the normal prostate epithelium (a), TAZ in the hyperplasia tissue (b), no expression of TAZ in the prostate cancer tissue (c); strong expression of TAZ in some prostate cancer tissues (d) were shown. Scale bar: 50μm (a,c,d), 100μm (b). (B) The expression level of TAZ is positively associated with basal marker TP63 and negatively correlated with the luminal markers CK8 and CK18. Co-expression data in the prostate cancer TCGA dataset were extracted from the cbioportal database. The Pearson’s correlation coefficient and Spearman’s correlation coefficient values were generated by the cbioportal.

For more information on Wanjin HONG's lab, please click here.